MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 3 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $179,334 | -64.3% | 5,400 | -84.7% | 0.02% | -66.7% |
| Q1 2018 | $503,000 | +1.4% | 35,400 | 0.0% | 0.07% | +1.5% |
| Q4 2017 | $496,000 | -2.0% | 35,400 | 0.0% | 0.06% | -7.1% |
| Q3 2017 | $506,000 | -9.3% | 35,400 | 0.0% | 0.07% | -16.7% |
| Q2 2017 | $558,000 | +14.1% | 35,400 | 0.0% | 0.08% | +18.3% |
| Q1 2017 | $489,000 | -22.0% | 35,400 | 0.0% | 0.07% | -25.3% |
| Q4 2016 | $627,000 | -8.2% | 35,400 | 0.0% | 0.10% | -4.0% |
| Q3 2016 | $683,000 | -1.0% | 35,400 | 0.0% | 0.10% | -6.6% |
| Q2 2016 | $690,000 | -5.3% | 35,400 | 0.0% | 0.11% | -13.8% |
| Q1 2016 | $729,000 | +0.3% | 35,400 | 0.0% | 0.12% | -4.7% |
| Q4 2015 | $727,000 | +20.2% | 35,400 | 0.0% | 0.13% | +22.9% |
| Q3 2015 | $605,000 | -8.3% | 35,400 | 0.0% | 0.10% | +10.5% |
| Q2 2015 | $660,000 | -2.2% | 35,400 | 0.0% | 0.10% | +6.7% |
| Q1 2015 | $675,000 | +15.8% | 35,400 | 0.0% | 0.09% | +15.6% |
| Q4 2014 | $583,000 | +9.8% | 35,400 | +18.0% | 0.08% | +5.5% |
| Q3 2014 | $531,000 | – | 30,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |